- Open Access
Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
Journal for ImmunoTherapy of Cancer volume 5, Article number: 88 (2017)
The original article was published in Journal for ImmunoTherapy of Cancer 2017 5:73
Unfortunately, after publication of this article , it was noticed that the name of Maarten A. Ligtenberg was displayed incorrectly as Maarten Ligtenberg. The correct author list can be seen above and the original article has been updated to reflect this.
Kremer V, Ligtenberg M, Zendehdel R, Seitz C, Duivenvoorden A, Wennerberg E, Lundqvist A. Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. Journal for Immunotherapy of Cancer. 2017;5:73. https://doi.org/10.1186/s40425-017-0275-9.
The online version of the original chapter can be found at 10.1186/s40425-017-0275-9.
About this article
Cite this article
Kremer, V., Ligtenberg, M.A., Zendehdel, R. et al. Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. j. immunotherapy cancer 5, 88 (2017). https://doi.org/10.1186/s40425-017-0292-8